pyrazolidine-3,5-dione: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 4295838 |
| SCHEMBL ID | 121542 |
| SCHEMBL ID | 16554341 |
| SCHEMBL ID | 23559298 |
| MeSH ID | M0410565 |
| Synonym |
|---|
| pyrazolidine-3,5-dione |
| AKOS000442373 |
| 3,5-pyrazolidinedione |
| 1,2-diazolidine-3,5-dione |
| STL372369 |
| SCHEMBL121542 |
| DNTVKOMHCDKATN-UHFFFAOYSA-N |
| 4744-71-2 |
| SCHEMBL16554341 |
| CS-0111719 |
| AS-57277 |
| 3,5 pyrazoline dione |
| SCHEMBL23559298 |
| EN300-3209119 |
| Z1278925673 |
| DTXSID101346761 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.34) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||